Local News

Biolex Reports Progress in Hepatitis C Treatment

Posted April 28, 2006 7:03 a.m. EDT

— Biolex Therapeutics

reported positive results in a Phase I trial of a proposed drug to treat Hepatitis C.

Biolex is developing the drug Locteron along with OctoPlus, a firm based in the Netherlands.

The drug is centered around a compound, BLX-883, developed by Biolex and a controlled-release drug delivery system designed by OctoPlus.

The two companies plan to launch Phase II clinical testing in the second half of this year.